Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

MYND
Mynd.ai, Inc.
stock NYSEAMERICAN ADR

At Close
Aug 19, 2026
0.4175USD-3.802%(-0.0165)9,260
0.00Bid   0.00Ask   0.0000Spread
Pre-market
Aug 18, 2026 8:16:30 AM EDT
0.4132USD-4.793%(-0.0208)1,000
After-hours
Aug 18, 2026 4:37:30 PM EDT
0.4400USD+7.317%(+0.0300)763
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 12, 2022
08:31AM EST  MYND Life Sciences Announces Collaborative Research Agreement with the   PR Newswire
Dec 17, 2021
09:34AM EST  MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat   PR Newswire
Dec 15, 2021
08:16AM EST  MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent   PR Newswire
Nov 30, 2021
07:23AM EST  MYND Life Sciences announces funding for Psilocybin research on   PR Newswire
Nov 18, 2021
10:07AM EST  MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker   PR Newswire
Nov 16, 2021
10:54AM EST  MYND Diagnostics Commences Clinical Research on Alzheimer's Disease   PR Newswire
Nov 9, 2021
07:10AM EST  MYND Executes LOI to Enter into a Clinical Research Collaboration with   PR Newswire
Oct 28, 2021
07:19AM EDT  MYND Life Sciences Announces Appointment of New Director   PR Newswire
Oct 27, 2021
07:25AM EDT  MYND Life To Acquire Rights For Use Of Psychedelics To Treat Alzheimer's Disease And Other Dementias   RTTNews
07:02AM EDT  MYND Life Sciences Signs Agreement to Acquire Rights for the Use of   PR Newswire
Oct 18, 2021
08:36AM EDT  KCSA Psychedelics Virtual Investor Conference Presentations Available for   PR Newswire
Oct 13, 2021
10:15AM EDT  MYND Diagnostics Inc. Announces Participation in a Monash University   PR Newswire
Oct 11, 2021
08:35AM EDT  MYND Life Sciences Inc. to Present at Psychedelics Virtual Investor Conference   PR Newswire
Oct 7, 2021
06:59AM EDT  MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned   PR Newswire
Sep 29, 2021
06:51AM EDT  MYND Life Sciences Inc. Announces RSU Grant   PR Newswire
Sep 9, 2021
07:02AM EDT  MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible   PR Newswire
Aug 26, 2021
07:08AM EDT  MYND Life Sciences Announces $3 Million Convertible Debenture Unit Offering   PR Newswire
Aug 11, 2021
06:44AM EDT  MYND Life Sciences Announces DTC Eligibility   PR Newswire
Jul 7, 2021
07:01AM EDT  MYND Life Sciences Provides Corporate Update   PR Newswire
Jun 23, 2021
08:09AM EDT  MYND Life Sciences Expands Intellectual Portfolio to Target Alzheimer's disease   PR Newswire
Jun 17, 2021
07:01AM EDT  MYND Life Sciences Announces LOI with Eyam Vaccines and Immunotherapeutics   PR Newswire
Jun 15, 2021
07:15AM EDT  MYND Life Sciences to Present at H.C. Wainwright Psychedelics in Psychiatry and   PR Newswire
Jun 10, 2021
07:02AM EDT  MYND Life Sciences Announces Patent Applications for Depression and   PR Newswire
Jun 1, 2021
07:02AM EDT  MYND Life Sciences announces Depression Biomarker Diagnostic Program   PR Newswire
May 28, 2021
07:01AM EDT  MYND Life Sciences Inc. Establishes Scientific Advisory Board   PR Newswire
May 26, 2021
07:15AM EDT  MYND Life Sciences Inc. Announces Public Listing On The Canadian Securities Exchange   RTTNews
07:02AM EDT  MYND Life Sciences Inc. Announces Public Listing on the Canadian Securities   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC